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The syndrome of sensory ataxic neuropathy with dysarthria and ophthalmoplegia 
(SANDO), defined genetically by mutations of the gene for the mitochondrial DNA 
polymerase-γ, POLG, was first described in 1997 (1). Since then, several case 
reports with various POLG, or more rarely PEO1, mutations have been published (2-
4), some specifically addressing muscle and nerve pathology (1, 3), nerve 
electrophysiology (5), or radiological aspects (4, 6, 7). At the molecular level, A467T 
and W748S POLG mutations were described in SANDO by Tzoulis and others (2-4). 
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Patients with the A467T mutation show various clinical phenotypes, ranging from 
lethal Alpers-Huttenlocher syndrome to relatively mild SANDO (3, 6). However, since 
SANDO syndrome is a relatively recently recognised and rare entity, no description of 
CNS pathology has been made until now. On magnetic resonance imaging of the 
brain, involvement was evidenced by inferior olivary hypertrophy and cerebellar 
atrophy (6). 
Comprehensive investigation of hypertrophy of the inferior olive showed that this 
process is almost exclusively secondary to deafferentation (8). This can occur at any 
site along the descending bisynaptic projection of the dentate nucleus to the inferior 
olive, also referred to as the Guillain - Mollaret triangle (9). Inferior olivary 
hypertrophy corresponds either to a lesion in the contralateral dentate nucleus or in 
the dentato-rubral projection before the fibres cross in the superior medullary velum. 
Alternatively, inferior olivary hypertrophy may be caused by an ipsilateral lesion in the 
already crossed dentato-rubral fibres, in the ipsilateral red nucleus, or the rubro-
olivary projections in the central tegmental tract. 
Here we present the first neuropathological documentation of cerebral changes in a 
patient with SANDO syndrome, thus enabling identification of the neuronal target 
regions of the genetic defect. 
This is the case of a 50 year-old female who presented with symptoms in her early 
twenties, when she noted impaired sensation in her feet on the pedals while driving. 
Subsequently, in her late thirties, she developed severe symmetrical sensory axonal 
neuropathy associated with frequent falls. Electroneurographical tests showed loss or 
pronounced amplitude reduction of sensory action potentials, while motor 
neurography was normal. Hence, the results were interpreted as pronounced axonal 
sensory polyneuropathy. In addition, horizontal and upward gaze palsy became 
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apparent. As the disease progressed, the patient developed diplopia, ptosis and 
dysarthria, pointing ataxia with pseudoathetosis, severe gait ataxia and dysaesthesia. 
The patient died suddenly of a cardiac arrest at the age of 50. Of note, the autopsy 
did not show any specific pathology in the cardio-pulmonary system. 
During the protracted course of the disease, laboratory tests (vitamins E and B12, 
anti-ganglioside antibodies, anti-Hu, -Ri, -Yo antibodies, phytanic acid, beta 
lipoproteins) were not diagnostic. Similarly, the cerebrospinal fluid showed, on one 
occasion, slightly elevated non-specific protein levels (0.62 g/L) and no oligoclonal 
bands. Early in the disease course, magnetic resonance imaging of the brain and 
spinal cord was normal, later the patient refused imaging. A sural nerve biopsy 
showed extensive loss of myelinated and non-myelinated axons accompanied by 
fibrosis. No inflammation or amyloid deposition were seen. The patient did not agree 
to a muscle biopsy (in retrospect, it might have shown COX negative and ragged red 
fibres). The mother and two sisters were healthy. Genetic tests for Charcot – Marie – 
Tooth 1a, Friedreich’s ataxia, spinocerebellar ataxia 1 and 3, Huntington’s disease 
and dentatorubro-pallidoluysian atrophy were all negative. Therapeutic trials with 
intravenous immunoglobulins proved to be ineffective. A CANOMAD syndrome 
(chronic ataxic neuropathy, ophthalmoplegia, IgM paraprotein, cold agglutinins, 
disialosyl antibodies) was considered: however, no corresponding anti-ganglioside 
antibodies were found. SANDO syndrome was also considered, but no genetic 
testing was done ante mortem. 
For neuropathology, only the brain but not the spinal cord or muscle were available. 
The formalin-fixed brain weighed 1268g. On gross inspection, the hemispheres were 
symmetrical and there was no evidence of atrophy or focal lesions. Significant 
macroscopic findings were localized to the brainstem and included protruding inferior 
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olives and pallor of the substantia nigra. Microscopically, pronounced gliosis and 
neuronal loss affected multiple neuroanatomical sites (Fig.1). Both inferior olives 
were remarkably prominent when examining the brainstem macroscopically in toto 
and on histological sections (Fig.1 A, B, C).  Striking microscopic changes were 
apparent in the inferior olives, where the ventral sections of the principal part showed 
marked gliotic change with gemistocytes and neuronal loss (Fig.1 D, F). The 
remaining neurones showed characteristic changes of inferior olivary hypertrophy (8) 
such as swollen rounded neurones with cytoplasmic vacuoles and plump dendritic 
processes (Fig.1 E). There was no apparent degeneration in the spinothalamic tract. 
In the posterior column – medial lemniscus pathway, the fasciculus gracilis showed 
pallor in both the HE and Luxol-PAS stains. More cranially in the brainstem and 
above, the medial lemniscus showed no obvious degeneration. The cerebellar cortex 
showed focal Purkinje cell loss accompanied by Bergmann gliosis (Fig. 1 G). In 
sections of midbrain, the substantia nigra, red nucleus and locus coeruleus showed 
pronounced nerve cell loss, astrogliosis and microgliosis. Similar degenerative 
changes were also observed in the dentate nucleus. In the substantia nigra, neuronal 
loss was most apparent in the pars compacta, where pigmented cells were scarce 
and free pigment clumps were disseminated in the parenchyma intermingled with 
prominent astrocytes (Fig. 1 H). A GFAP stain showed gliosis also in the pars 
reticulata. In the thalamus, the most pronounced gliotic change, as highlighted by 
immunohistochemistry for GFAP, was apparent in the lateral aspects of the ventral 
posterolateral nucleus (VPL). This pronounced gliotic change involved multiple 
structures in a stripe-like pattern. This gliotic stripe descended from the lateral-
posterior nucleus through the central and medial aspects of the VPLa. From there it 
ran along the lateral part of the VPLp and inferior VPLa, until and involving the 
ventral posteroinferior nucleus and the zona incerta. There, the stripe-like gliosis 
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sharply turned laterally through the ventromedial basal nucleus and ended in the 
lateral parts of the centromedian nucleus. Additionally, paraventricular parts of the 
anterior and mediodorsal (MD) nuclei were strongly affected. The MD was otherwise 
relatively spared except some foci of stronger gliosis. There was no cortical 
involvement; however, the lentiform nuclei showed neuronal loss and gliosis (Fig.1 J). 
Vacuolar change of gray matter was absent. 
Mutation analysis of POLG (NM_002693.2) was performed by Sanger sequencing 
and revealed heterozygosity for two missense variants. One was the c.1399G>A 
p.A467T and the second was the c.2243G>C p.W748S, both previously described in 
patients with SANDO syndrome (2-4). 
This is the first documentation of central neuropathological features in a patient with 
genetically confirmed SANDO syndrome. Our results demonstrate a pronounced 
multisystem degeneration with most extensive changes in rhombencephalic and 
mesencephalic structures, followed by less severe changes in the basal ganglia and 
thalamus. Specifically, degenerative changes were found within the dentate and red 
nuclei corresponding to the Guillain – Mollaret triangle, which caused the striking 
bilateral hypertrophy of the inferior olives. These pathological findings are in line with 
prior brain-imaging studies (4, 6, 7, 9) and the clinical manifestations of pronounced 
cerebellar ataxia. In the current case, imaging was declined by the patient in the 
further disease course, thus actual pathological correlation of imaging findings could 
not be provided. While inferior olivary hypertrophy follows most frequently 
cerebrovascular or posttraumatic lesions, or brain stem tumors (8, 9) and may 
manifest as palatal tremor (7, 10) that was not reported in our patient, symmetrical 
inferior olivary hypertrophy is rare. However, imaging studies showed that bilateral 
inferior olivary hypertrophy is a common feature in patients with POLG mutations (6).  
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In summary, this adult case of SANDO syndrome features a distinctive brain 
pathology that expands the spectrum of mitochondrial encephalopathies. The present 
report provides the basis for future studies on POLG mutations that might help to 
better understand the selective vulnerability of affected brain structures. 
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Figure caption 
Figure 1. Cerebral pathology in SANDO syndrome. Symmetrical hypertrophy of the 
inferior olives was striking macroscopically in toto (A, arrows), on coronal slices (B) 
and on histological sections (C). Microscopically the inferior olives showed 
gemistocytic gliosis (D) and neuronal swelling with cytoplasmic vacuoles and plump 
dendritic processes (E). Prominent gliosis throughout the inferior olives was also 
seen (F), as well as Bergmann gliosis of the cerebellar vermis (G). Further gliotic 
changes were seen in the substantia nigra (H) and in the red nucleus of the 
mesencephalon (I). Subcortically, profound affection of the caudate nucleus (J) and 
thalamus (K) was seen. Sections were stained with Luxol fast blue-Nissl (C), 
hematoxilin eosin (D, H); immunohistochemistry against neurofilaments 70 and 200 
kDa (E) and glial fibrillary acidic protein (F, G, I, J, K). Scale bars are 10 mm (A, B), 4 
mm (C), 75 µm (D), 30 µm (E), 500 µm (F, G), 200 µm (I, K), 100 µm (H, J).  
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